Novellia Raises $18M in Series A Funding Led by Spark Capital

The round also saw participation from Khosla Ventures, Acrew Capital, Bling Capital, and TMV. The round brought total funding raised to date to $28 million.

The company plans to use the funding to expand its AI-powered data technology, enhance its natural language processing infrastructure, and support the wider launch of its new consumer mobile app.

Researchers have long used real world data to understand how treatments work outside clinical trials. However, much of today’s healthcare data comes from third party providers that combine incomplete information from insurance claims and hospital records.

Novellia uses AI-powered technology to help patients access and organize their complete medical history from different healthcare providers through a free platform. Patients can also choose to share their data with researchers to support medical research and innovation.

The company provides deidentified and anonymized data to pharmaceutical and healthcare organizations, helping them develop new treatments and therapies. Its customers include several of the world's largest pharmaceutical companies as well as early-stage diagnostics firms.

Within seconds, Novellia helps patients collect and organize up to 20 years of medical records from hospitals, doctors, and laboratories across the United States.

Patients with serious or complex conditions often spend hours searching for records and repeating their medical history to new providers. Novellia simplifies this process with its AI-powered platform, bringing records together in one place and giving patients a free, complete view of their health information.

"I've known major pharma companies had data that was too old, too slow, and too disconnected from patients," said Alex Finkelstein, General Partner at Spark Capital. "For a long time, I looked for a company like Novellia. Shashi understood the problem firsthand and built the solution that benefits patients and research. Since Spark led the Series A, Novellia has signed some of the largest companies in the world to seven-figure, multi-year contracts. This is dramatically changing how medicines are developed."

Read More:Kish Bancorp, Inc. Welcomes Tracy Wilkinson as Chief Credit Officer

"Nearly 70% of patients are open to contributing data for medical breakthroughs, but they expect control, transparency and privacy safeguards," said Emma Silverman Partner at TMV. That gap between willingness and infrastructure is exactly what Novellia solves by creating a new category of patient consented data that is both more complete and more actionable for research."

"Behind every patient is a fragmented, incomplete record of their life," said Shashi Shankar, Co-Founder, and CEO of Novellia. "I watched this up close: first through my grandfather's cancer journey, and then professionally in pharma where we were developing therapies without ever seeing the full picture. The system failed patients and researchers at the same time. Novellia changes the course for this whole industry by putting the patient at the center."

About Novellia

Founded in 2023, by Shashi Shankar and Elliot Katz, Novellia helps patients quickly gather and organize years of medical records to improve care and support medical research. The company enables patients to share their health data with researchers on a voluntary basis, helping accelerate the development of new treatments and healthcare discoveries. It is focused on building a real-world data platform based entirely on information that patients choose to contribute for research.

Read More:Nubank Appoints Rob Livingston as Chief Financial Officer